Osman Khalid Waheed has been president/CEO of Ferozsons Laboratories since 1999. Under him, the company has expanded its portfolio of medical solutions for critical diseases by forging alliances with a number of leading international partners, including the US’s Boston Scientific, Argentina’s Bagó Group and Gilead Sciences. His partnership with Gilead has helped him bring its treatment for Hepatit